SEC Form 4Coverage since Jun 3, 2026
$TEVA insider trading
Over the last 12 months, Teva Pharmaceutical Industries insiders reported no purchases and 6 sales totaling $6.0M across SEC Form 4 filings. 83% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $6.0M 6 events
- Events · 12m
- 6 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 83% pre-arranged plans
Side
Price · $TEVA · 12Mvia TradingView
Top insiders · 12m
Shields MatthewEVP, Global Operations2× · $854K
Francis Richard DPresident and CEO1× · $211K
Jover PlacidSee "Remarks"1× · $447K
Hughes Eric ASee "Remarks"1× · $892K
Kalif Eliyahu SharonEVP, Chief Financial Officer1× · $3.6M
All insider trades
6 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Jover PlacidSee "Remarks" · O | ▼ Sale | 12,827 | $34.88 | $447K | -65.4% | plan |
| Aug 3, 2026 | Hughes Eric ASee "Remarks" · O | ▼ Sale | 25,578 | $34.88 | $892K | -15.9% | plan |
| Jun 18, 2026 | Shields MatthewEVP, Global Operations · O | ▼ Sale | 9,989 | $32.19 | $322K | -100% | — |
| Jun 11, 2026 | Kalif Eliyahu SharonEVP, Chief Financial Officer · O | ▼ Sale | 106,563 | $34.1 | $3.6M | -61.9% | plan |
| Jun 5, 2026 | Francis Richard DPresident and CEO · O | ▼ Sale | 6,153 | $34.35 | $211K | -0.5% | plan |
| Jun 3, 2026 | Shields MatthewEVP, Global Operations · O | ▼ Sale | 16,195 | $32.87 | $532K | -61.9% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TEVA feed.